← FDA Drug Approvals (Drugs@FDA)
DARUNAVIR
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: CIPLA · Approved 2023-11-28
Drug application
- FDA Application #
ANDA206288- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- DARUNAVIR
- Generic name
- DARUNAVIR
- Active ingredients
- DARUNAVIR
- Dosage form
- TABLET
- Route
- ORAL
- Marketing status
- None (Tentative Approval)
- Sponsor
- CIPLA
- Manufacturer
- Cipla USA Inc.
- First approval
- 2023-11-28
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown